Emergent BioSolutions Inc. (EBS)
NYSE·Healthcare·Biotechnology
$8.37
-0.30%
Mkt Cap $416.38M
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (3 analysts)
$12.00
Range $12.00 – $12.00
Implied Upside
+43.5%
Consensus $12.00 vs current $8.37
NYSE·Healthcare·Biotechnology
$8.37
-0.30%
Mkt Cap $416.38M
Buy
2
Hold
0
Sell
0
Price Target (3 analysts)
$12.00
Range $12.00 – $12.00
+43.5%
Consensus $12.00 vs current $8.37